AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remis, R. S.
Right arrow Articles by Lavoie, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remis, R. S.
Right arrow Articles by Lavoie, R.
Related Collections
Right arrow Immunization/Vaccines
Right arrow Hepatitis
Right arrow Sexual Health
Right arrow Drugs

American Journal of Public Health, Vol 90, Issue 10 1570-1574, Copyright © 2000 by American Public Health Association

JOURNAL ARTICLE

Association of hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group

RS Remis, A Dufour, M Alary, J Vincelette, J Otis, B Masse, B Turmel, R LeClerc, R Parent and R Lavoie
Department of Public Health Sciences, University of Toronto, Ontario, Canada. rs.remis@utoronto.ca

OBJECTIVES: This study determined the prevalence and factors associated with hepatitis B virus (HBV) infection among men who have sex with men. METHODS: At the baseline visit of an HIV study among men who have sex with men, we asked about HBV vaccination status and tested for HBV markers. RESULTS: Of 625 subjects, 48% had received at least 1 dose of HBV vaccine. Of 328 unvaccinated men, 41% had 1 or more HBV markers. HBV prevalence increased markedly with age and was associated with many sexual and drug-related behaviors. In a multivariate model, 7 variables were independently associated with HBV infection: ulcerative sexually transmitted diseases (odds ratio [OR] = 10.1; 95% confidence interval [CI] = 2.6, 54); injection drug use (OR = 5.2; 95% CI = 1.2, 26); gonorrhea or chlamydia (OR = 4.0; 95% CI = 1.9, 8.9); sexual partner with HIV/AIDS (OR = 3.6; 95% CI = 1.8, 7.1); 50 or more casual partners (OR = 3.4; 95% CI = 1.6, 7.1); received money for sex (OR = 3.0; 95% CI = 1.2, 7.8); and 20 or more regular partners (OR = 2.5; 95% CI = 1.1, 6.1). CONCLUSIONS: In Montreal, men who have sex with men are at risk for HBV infection, but a substantial proportion remain unvaccinated; new strategies are required to improve coverage. Men who have sex with men and who have a sexually transmitted infection, especially a genito-ulcerative infection, appear to be at particularly high risk for HBV infection.


This article has been cited by other articles:


Home page
 Postgrad. Med. J.Home page
G Rosner, Y Lurie, L Blendis, Z Halpern, and R Oren
Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.
Postgrad. Med. J., March 1, 2006; 82(965): 207 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
M. Alary, J. R. Joly, J. Vincelette, R. Lavoie, B. Turmel, and R. S. Remis
Lack of Evidence of Sexual Transmission of Hepatitis C Virus in a Prospective Cohort Study of Men Who Have Sex With Men
Am J Public Health, March 1, 2005; 95(3): 502 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Sex. Transm. Infect.Home page
L J Yee and S D Rhodes
Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned?
Sex Transm Inf, October 1, 2002; 78(5): 374 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
K. A. Page-Shafer, B. Cahoon-Young, J. D. Klausner, S. Morrow, F. Molitor, J. Ruiz, and W. McFarland
Hepatitis C Virus Infection in Young, Low-Income Women: The Role of Sexually Transmitted Infection as a Potential Cofactor for HCV Infection
Am J Public Health, April 1, 2002; 92(4): 670 - 676.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Public Health Association